Filippo Luciani Selected Research

Filippo Luciani Research Topics

3	Infections 01/2023 - 11/2021
3	COVID-19 04/2022 - 01/2021
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Virus Diseases (Viral Diseases) 12/2022
1	Chemical and Drug Induced Liver Injury 12/2022
1	Hepatitis B 12/2022
1	Severe Acute Respiratory Syndrome 04/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	Lung Injury 01/2021
1	Inflammation (Inflammations) 01/2018
1	Pruritus (Itching) 01/2018
1	Pneumonia (Pneumonitis) 06/2011
1	Chronic Renal Insufficiency 06/2011

3	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2011
1	MicroRNAs (MicroRNA)IBA 12/2022
1	XenobioticsIBA 12/2022
1	VaccinesIBA 04/2022
1	mRNA VaccinesIBA 04/2022
1	Proteins (Proteins, Gene)FDA Link 04/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2022
1	hydroxide ionIBA 11/2021
1	Vitamin D FDA LinkGeneric 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Pioglitazone (Actos)FDA Link 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	CanagliflozinIBA 01/2018

1	Polypharmacy 01/2023